
How to Initiate Treatment for Chronic Myelogenous Leukemia March 2016 vs July 2017
Jerald P. Radich, MD, Director of the Molecular Oncology Lab…

How to Treat Metastatic Colorectal Cancer
Bassel El-Rayes, MD, Professor and Vice Chair for Clinical Research,…

You, Me, and 23: DTC Gene Tests
Melinda Roberts, Web and Product Development Lead Globiana Inc.
Q:…

Leading Retractions in the Cancer Research Literature
Ivan Oransky, MD, is co-founder of Retraction Watch. Oransky…

Treating Metastatic Malignant Melanoma, March 2016 vs April 2017
Keith Flaherty, MD, Associate Professor of Medicine, Harvard…

Is the PBM Now Your Doctor?
Charles Bennett, MD, PhD, MPP, Smart State and Frank P and…

Preventing Breast Cancer: Research Worth Watching
Susan Love, MD, MBA Chief Visionary Officer, Dr. Susan Love Research…

2017 USPSTF on PSA: A Bad Idea
Richard J. Ablin, Ph.D., D.Sc. (hon), Dr. h.c. Professor, Department…

Big 2017 Change on PSA by USPSTF
Marc B Garnick, MD, Editor in Chief, HMS Annual Report on Prostate…

Forget Moonshots: Biomedicine Needs an Air Traffic Control System
Jeff Shrager, PhD, Director of Research, Cancer Commons; Adjunct…

Proposed FDA “Conditional Approval”- More Details
Al Musella, DPM, President, Musella Foundation For Brain Tumor…

Next Steps for Improving Clinical Evidence and Consistency of Payment for Precision Oncology
Kathryn A. Phillips, PhD, Professor of Health Economics and…

Conditional Approval: Right Solution for the Wrong Problem
Shannon Brownlee, MS, Senior Vice President of the Lown Institute,…

In Memorium: Richard E. Horowitz, M.D.
by Dr. George Lundberg
Searching for Truth in Cancer Clinical…

Fibrolamellar Hepatocellular Carcinoma: Still Rare but Deadly
John R. Craig, MD PhD, Retired pathologist and formerly Medical…

A Proposed New FDA Drug Approval Pathway: “Conditional”
Al Musella, DPM, President, Musella Foundation For Brain…

AACR: Advances in Immunotherapy to Continue
Srivani Ravoori, PhD, Associate Director, Science Communications;…

A Fully Integrated Histo-Molecular Pathology Report
Margaret L. Gulley, MD, Professor of Pathology and Laboratory…

Paying for Precision Oncology – Who Decides?
Patricia Deverka, Principal Researcher, Health Care Group
American…

A Plea for Gold Standards in Precision Oncology
George Lundberg, MS, MD, ScD, MASCP, FCAP, Chief Medical Officer…
